Dana Farber Cancer Institute /ID# 167009

Boston, Massachusetts 02215

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Acute Myeloid Leukemia (AML) Clinical Trial
A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Subjects With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Dana Farber Cancer Institute /ID# 167009
mi
from
Boston, MA
Click here to add this to my saved trials